SCHEMBL3923640

SCHEMBL3923640

FC(F)(F)COc1cccc(OCBr)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.50
ALDH1A1 P00352 4/20 0.50
GPR3 P46089 1/20 0.49
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
HTT P42858 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
LMNA P02545 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
S1PR2 O95136 1/20 0.43
S1PR4 O95977 1/20 0.43
GAA P10253 1/20 0.43
XBP1 P17861 1/20 0.43
PAX8 Q06710 1/20 0.43
S1PR3 Q99500 1/20 0.43
S1PR5 Q9H228 1/20 0.43
CYP2C9 P11712 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10972329 0.90 MAPT (0.59) MAPTALDH1A1GPR3GRIN1GRIN2A
SCHEMBL1770370 0.83 TP53 (0.50) ALDH1A1SMN1; SMN2LMNATP53CYP3A4
SCHEMBL9047357 0.81 CETP (0.47) MAPTALDH1A1GPR3GRIN1GRIN2A
SCHEMBL4141130 0.81 MAOB (0.41) ALDH1A1SMN1; SMN2TP53CYP3A4TSHR
SCHEMBL3250233 0.81 L3MBTL1 (0.54) ALDH1A1KMT2ALMNAKDM4EL3MBTL1
SCHEMBL24305918 0.81 MAPK1 (0.55) MAPTALDH1A1GPR3GRIN1GRIN2A
SCHEMBL9458046 0.81 GPR3 (0.49) MAPTALDH1A1GPR3GRIN1GRIN2A
SCHEMBL2494479 0.81 MAOB (0.53) MAPTALDH1A1GPR3GRIN1GRIN2A
SCHEMBL4573178 0.81 CETP (0.44) MAPTALDH1A1GPR3GRIN1GRIN2B
SCHEMBL1471132 0.81 MAOB (0.55) MAPTALDH1A1GPR3GRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009005460-A1 SMALL MOLECULE INHIBITORS OF NAVL.7 SODIUM CHANNELS FOR THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-01-08 WO disclosed